MA46580A - Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées - Google Patents
Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associéesInfo
- Publication number
- MA46580A MA46580A MA046580A MA46580A MA46580A MA 46580 A MA46580 A MA 46580A MA 046580 A MA046580 A MA 046580A MA 46580 A MA46580 A MA 46580A MA 46580 A MA46580 A MA 46580A
- Authority
- MA
- Morocco
- Prior art keywords
- influenza virus
- avian influenza
- vectors expressing
- virus antigens
- recombination vectors
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000006798 recombination Effects 0.000 title 1
- 238000005215 recombination Methods 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410885P | 2016-10-21 | 2016-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46580A true MA46580A (fr) | 2019-08-28 |
Family
ID=60452725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046580A MA46580A (fr) | 2016-10-21 | 2017-10-20 | Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11058761B2 (fr) |
| EP (2) | EP3528842A1 (fr) |
| KR (1) | KR20190073460A (fr) |
| CN (1) | CN110072548A (fr) |
| CA (1) | CA3041304A1 (fr) |
| IL (1) | IL266148B2 (fr) |
| JO (1) | JOP20190088A1 (fr) |
| MA (1) | MA46580A (fr) |
| MX (1) | MX385918B (fr) |
| MY (1) | MY191322A (fr) |
| PH (1) | PH12019500854A1 (fr) |
| RU (1) | RU2761869C2 (fr) |
| SA (1) | SA519401606B1 (fr) |
| TN (1) | TN2019000127A1 (fr) |
| TW (1) | TW201829454A (fr) |
| WO (1) | WO2018075977A1 (fr) |
| ZA (1) | ZA201902525B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2935643T3 (es) | 2016-06-17 | 2023-03-08 | Intervet Int Bv | Construcciones de virus de la enfermedad de Marek no patógeno recombinante que codifican antígenos del virus de la laringotraqueítis infecciosa y del virus de la bursitis infecciosa |
| JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
| JP7721269B2 (ja) | 2017-10-12 | 2025-08-12 | インターベット インターナショナル ベー． フェー． | 複数の異種抗原をコードする組換え非病原性マレック病ウイルス構築物 |
| JP7590329B2 (ja) * | 2018-12-21 | 2024-11-26 | セヴァ サンテ アニマレ | 複数の外来遺伝子を含む組換えトリヘルペスウイルス |
| KR102850522B1 (ko) | 2019-09-11 | 2025-08-26 | 조에티스 서비시즈 엘엘씨 | 조류 병원체의 항원을 발현하는 재조합 칠면조 헤르페스바이러스 벡터 및 이의 용도 |
| CN113827713B (zh) * | 2020-06-23 | 2024-07-05 | 普莱柯生物工程股份有限公司 | 一种抗h7亚型禽流感病毒的疫苗组合物、及其制备方法和应用 |
| CN113603754B (zh) * | 2021-08-23 | 2024-05-24 | 福建省农业科学院畜牧兽医研究所 | 一种水禽h5n8亚型流感病毒ha重组蛋白及其制备方法与应用 |
| CN113913394B (zh) * | 2021-10-19 | 2022-06-21 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 人工重组的h5n6流感病毒及其制备方法和应用 |
| CN114524862B (zh) * | 2021-12-16 | 2022-12-27 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 禽流感(h5+h7)三价dna疫苗的构建及其应用 |
| KR102846432B1 (ko) | 2022-11-15 | 2025-08-18 | 대한민국 | 재조합 h5n1 조류 인플루엔자 바이러스 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| KR20240087508A (ko) | 2022-11-25 | 2024-06-19 | 대한민국(농림축산식품부 농림축산검역본부장) | Clade 2.3.2.1d/2.3.4.4b에 속하는 고병원성 조류 인플루엔자 A 바이러스 예방용 재조합 다가 백신 조성물 및 이의 제조 방법 |
| CN120555370A (zh) * | 2024-02-29 | 2025-08-29 | 诗华动保科技(杭州)有限公司 | 重组hvt及其应用 |
| KR20250137779A (ko) | 2024-03-11 | 2025-09-19 | 대한민국(농림축산식품부 농림축산검역본부장) | Clade 2.3.4.4h에 속하는 재조합 조류 인플루엔자 A 바이러스 합성주, 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| KR20250137778A (ko) | 2024-03-11 | 2025-09-19 | 대한민국(농림축산식품부 농림축산검역본부장) | Clade 2.3.2.1d에 속하는 재조합 조류 인플루엔자 A 바이러스 합성주, 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| WO2025194003A1 (fr) * | 2024-03-13 | 2025-09-18 | Vst Llc Dba Medgene | Vaccins contre le virus de la grippe aviaire |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| DE69233158T2 (de) | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
| FR2728795B1 (fr) | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| US5980912A (en) | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
| US7371395B2 (en) | 2003-07-24 | 2008-05-13 | Merial Limited | Vaccine formulations |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US7910112B2 (en) | 2006-11-06 | 2011-03-22 | Merial Limited | Feline vaccines against avian influenza |
| CN101066448A (zh) * | 2007-05-25 | 2007-11-07 | 扬州大学 | 重组鸡痘病毒疫苗rFPV－1218AIH5/H9及其构建方法、用途 |
| FR2921387B1 (fr) * | 2007-09-26 | 2012-04-20 | Sanofi Pasteur | Procede de production du virus de la grippe |
| EP3542815A1 (fr) | 2008-11-28 | 2019-09-25 | Boehringer Ingelheim Animal Health USA Inc. | Vaccin contre la grippe aviaire recombiné et ses utilisations |
| CN101780275A (zh) * | 2009-01-21 | 2010-07-21 | 中国农业科学院哈尔滨兽医研究所 | H5n1亚型禽流感冷适应弱毒活疫苗的研制及其应用 |
| EP2414386B1 (fr) * | 2009-04-03 | 2016-01-27 | Merial Limited | Vaccins aviaires transportés par le virus de la maladie de newcastle |
| CN105567648B (zh) * | 2009-04-15 | 2019-09-03 | 法国诗华大药厂 | 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗 |
| UA107940C2 (en) | 2009-09-10 | 2015-03-10 | Merial Ltd | The vaccine composition that includes the saponin-containing adjuvant |
| CN103370079B (zh) * | 2010-10-18 | 2016-08-10 | 英特维特国际股份有限公司 | 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗 |
| EP2444441A1 (fr) * | 2010-10-19 | 2012-04-25 | Universiteit van Amsterdam | Procédé pour la préparation de polymère moussant |
| GB2484911B (en) | 2010-10-22 | 2013-04-03 | Johnson Matthey Plc | NOx absorber catalyst comprising caesium silicate and at least one platinum group metal |
| PL220281B1 (pl) * | 2011-09-23 | 2015-09-30 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA |
| DK3251691T3 (da) * | 2011-11-30 | 2020-02-10 | Boehringer Ingelheim Animal Health Usa Inc | Rekombinante hvt-vektorer der udtrykker antigener af fjerkræpatogener og anvendelser deraf |
| JOP20190088A1 (ar) * | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
-
2017
- 2017-06-16 JO JOP/2019/0088A patent/JOP20190088A1/ar unknown
- 2017-10-20 MY MYPI2019002163A patent/MY191322A/en unknown
- 2017-10-20 TW TW106136263A patent/TW201829454A/zh unknown
- 2017-10-20 MA MA046580A patent/MA46580A/fr unknown
- 2017-10-20 CA CA3041304A patent/CA3041304A1/fr active Pending
- 2017-10-20 EP EP17804329.5A patent/EP3528842A1/fr active Pending
- 2017-10-20 CN CN201780077418.4A patent/CN110072548A/zh active Pending
- 2017-10-20 US US15/789,936 patent/US11058761B2/en active Active
- 2017-10-20 KR KR1020197014459A patent/KR20190073460A/ko not_active Ceased
- 2017-10-20 RU RU2019115277A patent/RU2761869C2/ru active
- 2017-10-20 EP EP24161475.9A patent/EP4378528A3/fr active Pending
- 2017-10-20 MX MX2019004593A patent/MX385918B/es unknown
- 2017-10-20 TN TNP/2019/000127A patent/TN2019000127A1/en unknown
- 2017-10-20 WO PCT/US2017/057741 patent/WO2018075977A1/fr not_active Ceased
-
2019
- 2019-04-18 IL IL266148A patent/IL266148B2/en unknown
- 2019-04-18 SA SA519401606A patent/SA519401606B1/ar unknown
- 2019-04-22 PH PH12019500854A patent/PH12019500854A1/en unknown
- 2019-04-23 ZA ZA201902525A patent/ZA201902525B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110072548A (zh) | 2019-07-30 |
| RU2761869C2 (ru) | 2021-12-13 |
| IL266148A (en) | 2019-06-30 |
| PH12019500854A1 (en) | 2019-08-05 |
| MY191322A (en) | 2022-06-15 |
| WO2018075977A1 (fr) | 2018-04-26 |
| MX2019004593A (es) | 2019-08-14 |
| IL266148B (en) | 2022-10-01 |
| US11058761B2 (en) | 2021-07-13 |
| EP4378528A3 (fr) | 2024-12-04 |
| EP4378528A2 (fr) | 2024-06-05 |
| RU2019115277A3 (fr) | 2021-03-10 |
| TW201829454A (zh) | 2018-08-16 |
| EP3528842A1 (fr) | 2019-08-28 |
| IL266148B2 (en) | 2023-02-01 |
| JOP20190088A1 (ar) | 2019-04-21 |
| MX385918B (es) | 2025-03-18 |
| CA3041304A1 (fr) | 2018-04-26 |
| SA519401606B1 (ar) | 2022-08-25 |
| ZA201902525B (en) | 2020-11-25 |
| US20180110852A1 (en) | 2018-04-26 |
| RU2019115277A (ru) | 2020-11-23 |
| KR20190073460A (ko) | 2019-06-26 |
| TN2019000127A1 (en) | 2020-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46580A (fr) | Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées | |
| IL282985B (en) | Modified oncolytic viurs | |
| IL272183A (en) | Anti-cd8 antibodies and uses thereof | |
| EP3471767A4 (fr) | Hémagglutinines du virus de la grippe et utilisations de celles-ci | |
| PT3480307T (pt) | Novos vírus da vacina geneticamente modificados | |
| DK3565568T3 (da) | Ændret virus | |
| EP3538146A4 (fr) | Vaccin antigrippal | |
| EP3732191A4 (fr) | Récepteurs antigéniques chimériques améliorés et leurs utilisations | |
| EP3658165A4 (fr) | Vecteurs viraux oncolytiques et leurs utilisations | |
| EP4219350C0 (fr) | Système de tri de colis et d'articles | |
| EP3422853A4 (fr) | Insectifuge | |
| IL262092B (en) | Humanized anti-pacap antibodies and uses thereof | |
| EP3463447A4 (fr) | Régimes de vaccination contre le virus de la grippe | |
| EP3658163A4 (fr) | Récepteurs antigéniques chimériques améliorés et leurs utilisations | |
| PT3468990T (pt) | Anticorpos anti-c5 e utilizações dos mesmos | |
| LT3390441T (lt) | Žmogaus imunodeficito virusą neutralizuojantys antikūnai | |
| EP3659614C0 (fr) | Virus de la vaccine oncolytique | |
| MA45690A (fr) | Anticorps anti-tgfb, méthodes et utilisations | |
| EP3497209A4 (fr) | Compositions de poxvirus chimériques et leurs utilisations | |
| EP3362451A4 (fr) | Inhibiteurs de réplication du virus de la grippe, méthodes d'application et utilisations associées | |
| EP3334706A4 (fr) | Pillararènes et utilisations de ceux-ci | |
| DK3502112T3 (da) | Anti-influenza virus pyrimidinderivat | |
| LT3119431T (lt) | Antagonistiniai antikūnai, nukreipti prieš peptidą, susijusį su kalcitonino genu, ir jų panaudojimo būdai | |
| IL258079B (en) | Antigen receptors and uses thereof | |
| PL3439975T3 (pl) | Rękaw opakowaniowy, opakowanie i sposób wytwarzania opakowania |